Afatinib Expanded Access Program

NCT01649284 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: afatinib

Sponsor

Boehringer Ingelheim